Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Milestone Scientific (MLSS) EBT (2016 - 2025)

Milestone Scientific (MLSS) has disclosed EBT for 16 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • Quarterly EBT rose 46.42% to -$1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.7 million through Dec 2025, down 21.4% year-over-year, with the annual reading at -$5.7 million for FY2025, 21.4% down from the prior year.
  • EBT hit -$1.1 million in Q4 2025 for Milestone Scientific, up from -$1.2 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $223638.0 in Q2 2024 to a low of -$2.9 million in Q2 2022.
  • Historically, EBT has averaged -$1.7 million across 5 years, with a median of -$1.7 million in 2021.
  • Biggest five-year swings in EBT: surged 110.03% in 2024 and later tumbled 763.17% in 2025.
  • Year by year, EBT stood at -$1.5 million in 2021, then dropped by 28.56% to -$2.0 million in 2022, then increased by 1.52% to -$2.0 million in 2023, then dropped by 4.03% to -$2.0 million in 2024, then surged by 46.42% to -$1.1 million in 2025.
  • Business Quant data shows EBT for MLSS at -$1.1 million in Q4 2025, -$1.2 million in Q3 2025, and -$1.5 million in Q2 2025.